Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure

American Journal of Cardiology

Volumn 80, Issue 8, 1997, Pages 1101-1104

  Goldsmith, Rochelle L ^a   Bigger, J Thomas ^a   Bloomfield, Daniel M ^a   Krum, Henry ^a   Steinman, Richard C ^a   Sackner Bernstein, Jonathan ^a   Packer, Milton ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL;

ADULT; AGED; ARTICLE; CHOLINERGIC STIMULATION; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DOSE TIME EFFECT RELATION; EXERCISE TOLERANCE; FEMALE; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART FUNCTION TEST; HEART RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBAZOLES; CHRONIC DISEASE; DIGOXIN; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PARASYMPATHETIC NERVOUS SYSTEM; PROPANOLAMINES;

EID: 0030726481     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00616-4     Document Type: Article

References (28)

1. Cohn JN, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
2. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877-883.
3. Binkley PF, Nunziata E, Haas GJ, Wilson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cordiol 1991;18:464-472.
4. Nolan J, Flapan AD, Capewell S, MacDonald T, JMM N, Ewing D. Decreased cardiac parasympathetic activity in chronic heart failure. Br Heart J 1992;67: 482-485.
5. Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993;21:655-661.
6. Krum H, Bigger JT, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995;25:289-294.
7. Krum H, Sackner-Bernstien JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995;92:1499-1506.
8. Eichhorn E, Heesch C, Barnett J, Alvarez L, Fass S, Grayburn P, Hatfield B, Marcoux L, Malloy C. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1994;24:1310-1320.
9. Packer M, Bristow M, Cohn J, Colucci W, Fowler M, Gilbert E, Shusterman N. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
10. Ruffulo R, Gelai M, Heible J, Willette R, Nichols A. The pharmacology of carvedilol. Eur J Clin Pharmacol 1990;38 (suppl 2):S82-S88.
11. Yue T-L, Cheng H-Y, Lysko P, McKenna P, Feuerstein R, Gu J, Lysko K, Davis L, Feuerstein G. Carvedilol, a new vasodilator and beta-adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992;263:92-98.
12. Ohlstein E, Douglas S, Sung C, Yue T, Louden C, Arleth A, Poste G, Ruffalo R, Feuerstein G. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration and neointimal formation following vascular injury. Proc Natl Acad Sci USA 1993;90:6189-6193.
13. Cook JR, Bigger JT, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 1991;17:480-484.
14. Guidera SA, Bigger JT, Steinman RC, Rolnitzky LM. Beta blockers increase vagal tone after myocardial infarction. Circulation 1990:82 (suppl III)III-1-III-39.
15. Niemela MJ, Airaksinen KEJ, Huikuri HV. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 1994;23:1370-1377.
16. Sandrone G, Mortara A, Torzillo D, La Rovere M, Malliani A, Lombardi F. Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol 1994;74:340-345.
17. Albrecht P, Cohen R. Estimation of heart rate power spectrum bands from real-world data: dealing with ectopic beats and noisy data. Comput Cardiol 1988;15:311-314.
18. Rottman JN, Steinman RC, Albrecht P, Bigger JT, Rolnitzky LM, Fleiss JL. Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. Am J Cardiol 1990;66:1522-1524.
19. Fleiss JL. Design and Analysis of Clinical Experiments. New York City: Wiley, 1986:65-67.
20. Bigger JT, Fleiss JL, Steinman RC, Rolintzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-age persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995;91:1936-1943.
21. Schwartz BM, Sackner-Bernstein J, Penn J, Medina N, Yushak M, Goldsmith RL, Kukin ML, Packer M. Which patients with chronic heart failure are most likely to show hemodynamic and functional improvement following long-term beta-blockade? (abstr) J Am Coll Cardiol 1992;19:341A.
22. CIBIS Investigators and Committees. A randomized trial of b-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-1773.
23. Bittner SB, Smith SE. β-adrenoceptor antagonists increase sinus arrhythmia, a vagotonic effect. Br J Clin Pharmacol 1986;22:691-695.
24. Coker R, Koziell A, Oliver C, Smith SE. Does the sympathetic nervous system influence sinus arryhthmia in man? Evidence from combined autonomic blockade. J Physiol 1984;356:459-464.
25. Schwartz PJ, Pagani M, Lombardi F. A cardio-cardiac sympatho-vagal reflex in the cat. Circ Res 1973;32:215-220.
26. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1937;316:1429-1435.
27. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
28. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992:85(suppl I):I-77-I-91.